| Patient | Fannie Lou Hamer |
|---|---|
| Date of birth | 1976-10-06 |
| Identifiers | MRN HR-ML031-SYN; SSN (made up) 000-31-2479 |
| Document date | 2026-03-09 |
| Author | Lorraine Batiste-Hill, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care at the rural community health center for high blood pressure readings, thirst and frequent urination, leg and back aching, and reduced vision in the left eye since an old injury, with consent-based, trauma-informed care and a social needs screen. [S]
Hemoglobin A1c: 8.6% (high); Glucose (random): 238 mg/dL (high); Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.96 mg/dL; eGFR (CKD-EPI 2021): 73 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 88 mg/g (high); Total cholesterol: 228 mg/dL (high); LDL cholesterol: 146 mg/dL (high); HDL cholesterol: 44 mg/dL (low); Triglycerides: 190 mg/dL (high); ALT: 24 U/L; AST: 22 U/L; Hemoglobin: 12.6 g/dL; Platelets: 268 10*3/uL; TSH: 2.1 mIU/L; PHQ-9: 4; AHC-HRSN screen: core needs positive (0 to 5): 3. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-09 | Body height | 163 | cm | S |
| 2026-03-09 | Body weight | 93 | kg | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 35 | kg/m2 | S |
| 2026-03-09 | Systolic blood pressure | 164 | mm[Hg] | S |
| 2026-03-09 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 2026-03-09 | Heart rate | 84 | /min | S |
| 2026-03-09 | Respiratory rate | 16 | /min | S |
| 2026-03-09 | Body temperature | 36.8 | Cel | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 8.6 | % | Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for her | High | S |
| 2026-03-09 | Glucose [Mass/volume] in Serum or Plasma | 238 | mg/dL | Random sample; 200 mg/dL or higher with symptoms is diagnostic of diabetes | High | S |
| 2026-03-09 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-09 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 73 | mL/min/{1.73_m2} | 90 or higher is normal; 60 to 89 is mildly decreased (G2) | Low | S |
| 2026-03-09 | Albumin/Creatinine [Mass Ratio] in Urine | 88 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
| 2026-03-09 | Cholesterol [Mass/volume] in Serum or Plasma | 228 | mg/dL | <=199 mg/dL | High | S |
| 2026-03-09 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 146 | mg/dL | Goal below 70 mg/dL with diabetes and kidney disease | High | S |
| 2026-03-09 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=50 mg/dL | Low | S |
| 2026-03-09 | Triglyceride [Mass/volume] in Serum or Plasma | 190 | mg/dL | <=149 mg/dL | High | S |
| 2026-03-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-35 U/L | Normal | S |
| 2026-03-09 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 10-35 U/L | Normal | S |
| 2026-03-09 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 12-15.5 g/dL | Normal | S |
| 2026-03-09 | Platelets [#/volume] in Blood by Automated count | 268 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-09 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-03-09 | Accountable health communities (AHC) health-related social needs screening (HRSN) tool | 3 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening meal | Two tablets with the evening meal (after one week of one tablet) | Oral route | 2026-03-09 to 2026-07-13 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later life | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes is documented only at the end of her life. |
| Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirm | active | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigated | active | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented. |
| Food insecurity: food runs out before the end of most months | active | confirmed | Z59.41 | S — Synthetic social need found on the screen. |
| Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrange | active | confirmed | Z59.82 | S — Synthetic social need anchored to her rural Delta home. |
| Hyperlipidemia: LDL 146 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |